Drug Profile
Research programme: viral vaccines - Spotlight Innovation
Alternative Names: Immunoplex™ Ebola; Immunoplex™ HA flu; Immunoplex™ HepBLatest Information Update: 13 Oct 2016
Price :
$50
*
At a glance
- Originator Memcine Pharmaceuticals
- Developer Spotlight Innovation
- Class Hepatitis B vaccines; Influenza virus vaccines; Peptide vaccines; Viral vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Ebola virus infections; Hepatitis B; Influenza virus infections